Authors

• Marek Kokot
• Lars Pettersson (ORCID: https://orcid.org/0000-0001-5745-508X)
• Matthew Camiolo (ORCID: https://orcid.org/0000-0002-9085-6552)
• David Petullo
• Kathryn Collison (ORCID: https://orcid.org/0000-0001-6315-0450)
• Christer Gottfridsson
• K Kucz
• Omar S. Usmani (ORCID: https://orcid.org/0000-0002-4367-254X)
• Patrik Bondarov
• Mehul Patel (ORCID: https://orcid.org/0000-0002-5681-5888)
• Artur Bednarczyk
• Magnus Aurivillius (ORCID: https://orcid.org/0000-0003-4660-5040)
• Hitesh Pandya (ORCID: https://orcid.org/0000-0003-0514-2529)
• Fernando J. Martínez (ORCID: https://orcid.org/0000-0002-2412-3182)
• Jie Mei
• Jennifer Bell (ORCID: https://orcid.org/0000-0003-2858-5576)
• Mandeep Jassal
• Karin Skansen

Institutions

• University of Massachusetts Chan Medical School (US)
• Royal Brompton Hospital (GB)
• AstraZeneca (Australia) (AU)
• AstraZeneca (Brazil) (BR)
• AstraZeneca (Switzerland) (CH)
• MRC Biostatistics Unit (GB)
• AstraZeneca (Poland) (PL)
• AstraZeneca (Finland) (FI)
• AstraZeneca (Italy) (IT)
• AstraZeneca (Sweden) (SE)
• AstraZeneca (Spain) (ES)
• Imperial College London (GB)

Publication Details

Journal

EClinicalMedicine

Published

2025-08-12

DOI

https://doi.org/10.1016/j.eclinm.2025.103402

Citations

1

Primary Topic

Chronic Obstructive Pulmonary Disease (COPD) Research

Type

article

Field-Weighted Citation Impact

1.52